Long circulating liposomes: Past, present and future

Biotechnology Advances

Volumn 14, Issue 2, 1996, Pages 151-175

  Marjan, Jihan M J ^a   Allen, Theresa M ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIODEGRADATION; CELL MEMBRANES; CELLS; DRUG PRODUCTS; DRUG THERAPY; ENZYMES; MOLECULAR STRUCTURE; MOLECULES; POLYETHYLENE GLYCOLS; POLYPEPTIDES;

DISEASED CELL; DRUG CARRIERS; HYDROPHILLIC HEADS; LIPOSOMAL DRUG CARRIERS; LIPOSOMAL FORMULATING; LIPOSOMES; MODEL MEMBRANES; NONPOLAR HYDROPHOBIC TAILS; SITE SELECTIVE DELIVERY;

LIPIDS;

EID: 0029699247     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/0734-9750(96)00007-9     Document Type: Review

References (57)

1. Bangham, A.D., Standish, M.M., Watkins, J.C. Diffusion of univalent ions across the lamellae of swollen phospholipids. J. Mol. Biol. 13:328-252, 1965.
2. Allen, T.M. and Chonn, A. Large unilamellar liposomes with low uptake into the reticuloendothelial system. FEBS Lett., 223:42-46, 1987.
3. Gabizon, A. and Papahadjopoulos, D. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc. Natl. Acad. Sci. USA, 85:6949-4953, 1988.
4. Allen, T.M. Stealth liposomes, Avoiding reticuloendothelial uptake, in Liposomes in the Therapy of Infectious Diseases and Cancer, New Series, Vol. 89, Eds. G. Lopez-Berestein and I. Fidler, Alan R. Liss Inc, New York, 1989, pp. 405-415.
5. Allen, T.M. and Papahadjopoulos, D. Sterically stabilized ("Stealth") liposomes: Pharmacokinetics and therapeutic advantages in: Liposome Technology, 2nd Edition, Vol. 111, Ed. G. Gregoriadis, CRC Press, Boca Raton, Florida, 1993 pp. 59-72.
6. Mumtaz, S., Ghosh, P.C. and Bachhawat, B.K. Design of liposomes for circumventing the reticuloendothelial cells. Glycobiol., 1:505-510, 1991.
7. Blume G. and Cevc, G. Molecular mechanism of the lipid vesicle longevity in vivo. Biochim. Biophys. Acta, 1029:91-97, 1990.
8. Chonn, A., Semple, S.C. and Cullis, P.R. Association of blood proteins with large unilamellar liposomes in vivo, Relation to circulation lifetimes. J. Biol. Chem., 267:18759-18765, 1992.
9. Gabizon, A. and Papahadjopoulos, D. The role of surface charge and hydrophillic groups on liposome clearance in vivo. Biochim. Biophys. Acta, 1103:94-100, 1992.
10. Lasic, D.D., Martin, F.J., Gabizon, A., Huang, S.K. and Papahadjopoulos, D. Sterically stabilized liposomes, A hypothesis on the molecular origin of the extended circulation times. Biochim. Biophys. Acta, 1070:187-192, 1991.
11. Needham, D., Kristova, K., McIntosh, T.J., Dewhirst, M., Wu, N. and Lasic D.D. Polymer-grafted liposomes, Physical basis for the "Stealth" property. J. Liposome Res., 2:411-430, 1992.
12. Woodle, M.C. and Lasic D.D. Sterically stabilized liposomes. Biochim. Biophys. Acta, 1113:171-199, 1992.
13. Pool, R. "Hairy" enzymes stay in the blood. Science, 248:305, 1990.
14. Torchilin, V.P, Omelyanenko, V.G., Papisov, M.I., Bogdanov, A.A., Trubetskoy, V.S., Herron, J.N., Gentry, C.A. Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity. Biochim. Biophys. Acta, 1195:11-20, 1995.
15. Needham, D., McIntosh, T.J., Lasic, D.D. Repulsive interactions and mechanical stability of polymer-grafted lipid membranes. Biochim. Biophys. Acta, 1108:40-48, 1992.
16. Gabizon, A., Dagan, A., Goren, D., Barenholz, Y. and Fuks, A. Liposomes as in vivo carriers of adriamycin, Reduced cardiac uptake and preserved antitumour activity in mice. Cancer Res., 42:4734-4739, 1982.
17. Maruyama, K., Yuda, T., Okamoto, A., Ishikura, C., Kojima, S., Iwatsuru, M. Effect of molecular weight in amphipathic polyethylene glycol on prolonging the circulation time of large unilamellar liposomes. Chem. Pharm. Bull, 39:1620-1622, 1991.
18. Woodle, M.C. Surface modified liposomes: assessment and stability and prolonged circulation. Chem. Phys. Lipids, 64:249-262, 1993.
19. Zalipsky, S., Hansen, C.B., Oaks, J.M. and Allen, T.M. Evaluation of blood clearance and biodistribution of poly(2-oxazoline)-grafted liposomes. J. Pharm. Sci., (in press).
20. Torchilin, V.P., Shtilman, M.I., Trubetskoy, V.S., Whiteman, K., Milstein, A.M. Amphiphilic vinyl polymers effectively prolong liposome circulation time in vivo. Biochim. Biophys. Acta., 1195:181-184, 1994.
21. Olson, F., Hunt, C.A., Szoka, F.C., Vail, W.J., Papahadjopoulos, D. Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes. Biochim. Biophys. Acta, 557:9-23, 1979.
22. Litzinger, D.C., Buiting, A.M.J., van Rooijen, N., Huang, L. Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes. Biochim. Biophys. Acta, 1190:99-107, 1994.
23. Papahadjopoulos, D., Allen, T.M., Gabizon, A., Mayhew, E., Matthay, K., Huang, S.K., Lee, K.D., Woodle, M.C., Lasic, D.D., Redemann, C., Martin, F.J. Sterically stabilized liposomes: Improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc. Natl. Acad. Sci. USA, 88:11460-11464, 1991.
24. Allen, T.M., Hansen, C.B., de Menezes, D.E.L. Pharmacokinetics of long-circulating liposomes. Adv. Drug. Deliv. Rev., 16:267-285, 1995.
25. Mayer, L.D., Tai, L.C.L., Bally, M.B., Mitilenes, G.N., Ginsberg, R.S., Cullis, P.R. Characterization of liposomal systems containing doxorubicin entrapped in response to pH gradients. Biochim.Biophys.Acta 1025:143-151, 1990.
26. Mayer, L.D., Bally, M.B., Cullis, P.R. Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient. Biochim.Biophys.Acta 857:123-126, 1986.
27. Haran, G., Cohen, R., Bar, L.K., Barenholz, Y. Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases. Biochim.Biophys.Acta. 1151:201-215, 1993.
28. Dvorak, H.F., Nagy, J.A., Dvorak, J.T., Dvorak, A.M. Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules Am. J. Pathol., 133:95-109, 1988.
29. Wu, N.Z., Da, D., Rudoll, T.L., Needham, D., Dewhirst, M.W. Increased microvascular permeability contributes to preferential accumulation of Stealth liposomes in tumor tissue. Cancer Res., 53:3765- 3770, 1993.
30. Allen, T.M. and Mehra T. Recent advances in sustained release of antineoplastic drugs using liposomes which avoid uptake in to the reticuloendothelial system. Proc. Western Pharmacol. Soc., 32:111-114, 1989.
31. Baguley, B.C. and Falkenhaug, E.M. Plasma half-life of cytosine arabinoside (NSC-63878) in patients treated for acute myeloblastic leukaemia. Cancer Chemother. Rep., 55:291-298 (1971)
32. Borsa, J., Whitmore, G.R., Valeriote, F.A., Collines, D. and Bruce, W.R. Studies on the persistence of methotrexate, cytosine arabinoside and leucovorin in the serum of mice. J. Nat. Cancer Inst., 42:235-242, 1969.
33. Allen, T.M., Mehra, T., Hansen, C., Chin, Y-C. Stealth liposomes: an improved sustained release system for 1-β-D-arabinofuranosylcytosine. Cancer Res., 52:2431-2439, 1992.
34. Allen, T.M., Newman, M.S., Woodle, M.C., Mayhew, E., Uster, P.S. Pharmacokinetics and antitumor activity of vincristine encapsulated in sterically stabilized liposomes. Int. J. Cancer, 62:199-204, 1995
35. Vaage, J., Donovan, A., Mayhew, E., Uster, P., Woodle, M. Therapy of mouse mammary carcinomas with vincristine and doxorubicin encapsulated in sterically stabilized liposomes. Int. J. Cancer, 54:959-964, 1993.
36. Ahmad, I., Longenecker, M., Samuel, J. and Allen, T.M. Antibody-targeted delivery of doxorubicin entrapped in sterically stabilized liposomes can eradicate lung cancer in mice. Cancer Res., 53:1484-1488, 1993.
37. Gabizon, A.A. Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes. Cancer Res., 52:891-896, 1992.
38. Jain, R.K. Transport of molecules across tumor vasculature. Cancer Metastasis Rev., 6:559-593, 1987.
39. Mayhew, E.G., Lasic, D., Babbar, S., and Martin, F.J. Pharmacokinetics and antitumor activity of epirubicin encapsulated in long-circulating liposomes incorporating a polyethylene glycol-derivatized phospholipid. Int. J. Cancer, 51:302-309, 1992.
40. Papahadjopoulos, D., Allen, T.M., Gabizon, A., Mayhew, E., Matthay, K., Huang, S.L., Lee, K-D, Woodle, M.C., Lasic, D.D., Redemann, C. and Martin, F.J. Sterically stabilized liposomes, Improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc. Natl. Acad. Sci. USA, 88:11460-11464, 1991.
41. Vaage, J., Mayhew, E., Lasic, D.D. and Martin, F.J. Therapy of primary and metastatic mouse mammary carcinomas with doxorubicin encapsulated in long circulating liposomes. Int. J. Cancer, 51:942-948, 1992.
42. Williams, S.S., Alosco, T.R., Mayhew, E., Lasic, D.D., Martin, F.J., and Bankert, R.B. Arrest of human lung tumor xenograft grown in severe combined immunodeficient mice using doxorubicin encapsulated in sterically stabilized liposomes. Cancer Res., 53:3964-3967, 1993.
43. Bakker-Woudenberg, I.A.J.M., Storm, G., Woodle, M.C. Liposomes in the treatment of infections. J. Drug Targeting, 2:363-371, 1994.
44. Miller, N., Vile, R. Targeted vectors for gene therapy. FASEB J., 9:190-199, 1995.
45. Weissleder, R., Bogdanov, A., Neuwlt, E.A., Papisov, M. Long circulating iron oxides for magnetic resonance imaging. Adv. Drug Deliv. Rev., 16:3231-334, 1995.
46. Bogdanov, A.Jr., Weissleder, R., Brady, T. Long circulating blood pool imaging agents. Adv. Drug Deliv. Rev., 16:335-348, 1995.
47. Northfelt, D.W., Martin, F.J., Kaplan, L.D., Russell, J., Anderson, M., Lang, J., Volberding, P.A. Pharmacokinetics, tumor localization and safety of Doxil (liposomal Doxorubicin) in AIDS patients with Kaposi's sarcoma. Proc. Am. Soc. Clin. Oncol., 12:51, 1993.
48. Gill, P.S., Espina, B.M., Muggia, F., Cabriales, S., Tulpule, A., Esplin, J.A., Liebman, H.A., Forssen, E., Ross, M.E., Levine, A.M. Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin. J. Clin. Oncol., 13:996-1003, 1995.
49. Hansen, C.B., Kao, G.Y., Moase, E.H., Zalipsky, S., Allen, T.M. Attachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling procedures. Biochim. Biophys. Acta, 1239:133-144, 1995.
50. Allen, T.M., Ahmad, I., Lopes de Menezes, D.E., Moase, E.H. Immunoliposome-mediated targeting of anticancer drugs in vivo. Biochem. Society Trans., 23:1073-1079,1995.
51. Weinstein, J.N. and van Osdol, W. Early intervention in cancer using monoclonal antibodies and other biological ligands:micropharmacology and the "Binding Site Barrier". Cancer Res., 52:2747-2751, 1992.
52. Allen, T.M. Long-circulating (sterically stabilized) liposomes for targeted drug delivery. Trends in Pharmacological Sciences, 15:215-220, 1994.
53. Vingerhoeds, M.H., Storm, G., Crommelin, D.J.A. Immunoliposomes in vivo. Immunomethods, 4:259-272, 1994.
54. R) liposomes. J. Liposome Res., 4:1-25, 1994.
55. Neuberger, M.S., Williams, G.T., Mitchell, E.B., Jouhal, S.S., Flanagan, J.G., Rabbitts, T.H. A hapten-specific chimeric IgE antibody with human physiological effector function. Nature, 314:268-270, 1985.
56. LoBuglio, A.F., Wheeler, R.H., Trang, J., Haynes, A., Rogers, K., Harvey, E.B., Sun, L., Ghrayeb, J., Khazaeli, M.B. Mouse/human chimeric monoclonal antibody in man: kinetics and immune response. Proc. Natl. Acad. Sci. USA, 86:4220-4224, 1989.
57. Hale, G., Dyer, M.J., Clark, M.R., Phillips, J.M., Marcus, R., Reichmann, L., Winter, G., Waldmann, H. Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH-1H. Lancet, ii(8625):1394-1399, 1988.